Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
564
-
Total 13F shares, excl. options
-
71.8M
-
Shares change
-
-1.72M
-
Total reported value, excl. options
-
$26.3B
-
Value change
-
-$645M
-
Put/Call ratio
-
0.91
-
Number of buys
-
266
-
Number of sells
-
-230
-
Price
-
$367.09
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2016
672 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2016.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 564 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.8M shares
of 105M outstanding shares and own 68.35% of the company stock.
Largest 10 shareholders include FMR LLC (7.82M shares), Capital World Investors (7.76M shares), WELLINGTON MANAGEMENT GROUP LLP (5.69M shares), VANGUARD GROUP INC (4.92M shares), STATE STREET CORP (3.24M shares), BlackRock Fund Advisors (2.45M shares), SANDS CAPITAL MANAGEMENT, LLC (2.3M shares), BlackRock Institutional Trust Company, N.A. (2.04M shares), JENNISON ASSOCIATES LLC (1.92M shares), and Artisan Partners Limited Partnership (1.89M shares).
This table shows the top 564 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.